UAB trial shows first-in-human immunotherapy that more than doubles progression-free survival in glioblastoma patients
July 09, 2026
July 09, 2026
BIRMINGHAM, Alabama, July 9 -- The University of Alabama issued the following news:
* * *
UAB trial shows first-in-human immunotherapy that more than doubles progression-free survival in glioblastoma patients
*
Phase 1 trial results of a glioblastoma study ledy by Burt, Nabors, MD, offer new optimism for improved survival and quality of life for patients. Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most . . .
* * *
UAB trial shows first-in-human immunotherapy that more than doubles progression-free survival in glioblastoma patients
*
Phase 1 trial results of a glioblastoma study ledy by Burt, Nabors, MD, offer new optimism for improved survival and quality of life for patients. Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most . . .